XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Collaboration revenue $ 706 $ 0 $ 706 $ 0
Operating expenses:        
Research and development 24,149 20,510 77,880 56,945
General and administrative 10,661 8,504 29,745 25,022
Total operating expenses 34,810 29,014 107,625 81,967
Loss from operations (34,104) (29,014) (106,919) (81,967)
Other income (expense):        
Interest and investment income 2,498 4,517 8,733 13,405
Other expense, net (37) (37) (218) (72)
Total other income, net 2,461 4,480 8,515 13,333
Net loss $ (31,643) $ (24,534) $ (98,404) $ (68,634)
Net loss per share attributable to common shareholders - basic $ (0.55) $ (0.42) $ (1.7) $ (1.24)
Net loss per share attributable to common shareholders - diluted $ (0.55) $ (0.42) $ (1.7) $ (1.24)
Weighted-average common shares outstanding used in net loss per share - basic 58,005,928 57,820,458 58,005,520 55,542,074
Weighted-average common shares outstanding used in net loss per share - diluted 58,005,928 57,820,458 58,005,520 55,542,074